Magnesium isoglycyrrhizinate protects against renal-ischemia-reperfusion injury in a rat model via anti-inflammation, anti-oxidation and anti-apoptosis
Authors:
Open Access
- 1 March 2017
- journal article
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 16 (3) , 3627-3633
Abstract
The present study aimed to investigate whether magnesium isoglycyrrhizinate protects against renal ischemia‑reperfusion injury (RIRI), and to verify the underlying mechanisms. An RIRI rat model was induced by removing the right kidney, and exposing and clamping the left kidney. RIRI model rats were administered 30 mg/kg magnesium isoglycyrrhizinate for 3 days. Blood urea nitrogen (BUN) and serum creatinine levels in the blood of RIRI model rat were examined, compared with sham‑operated controls. Magnesium isoglycyrrhizinate suppressed the activities of tumor necrosis factor‑α, interleukin (IL)‑1β, IL‑6, superoxide dismutase, glutathione peroxidase, inducible nitric oxide synthase (iNOS) and caspase‑3 in RIRI model rats. Renal iNOS, matrix metalloproteinase (MMP)‑2, phosphorylated‑signal transducers and activators of transcription 3 (STAT3) and intercellular adhesion molecule‑1 (ICAM‑1) protein expression levels were suppressed by magnesium isoglycyrrhizinate treatment in RIRI model rats. These findings suggested that magnesium isoglycyrrhizinate protects RIRI via anti‑inflammatory, ‑oxidative and ‑apoptotic mechanisms in an RIRI rat model. These results implicate magnesium isoglycyrrhizinate pretreatment as a potential approach to protect against RIRI via suppression of the iNOS, ICAM‑1, MMP‑2 and STAT3 signaling pathways.Keywords
This publication has 28 references indexed in Scilit:
- Improving the outcome of kidney transplantation by ameliorating renal ischemia reperfusion injury: lost in translation?Journal of Translational Medicine, 2016
- Matrix Metalloproteinase-2 (MMP-2) Gene Deletion Enhances MMP-9 Activity, Impairs PARP-1 Degradation, and Exacerbates Hepatic Ischemia and Reperfusion Injury in MicePLOS ONE, 2015
- Perioperative elafin for ischaemia-reperfusion injury during coronary artery bypass graft surgery: a randomised-controlled trialHeart, 2015
- Association between matrix metalloproteinase-2 and matrix metalloproteinase-9 polymorphisms and endometriosis: A systematic review and meta-analysisBiomedical Reports, 2015
- Dexmedetomidine on renal ischemia-reperfusion injury in rats: assessment by means of NGAL and histologyRenal Failure, 2015
- Effect of Puerarin on Expression of ICAM-1 and TNF-α in Kidneys of Diabetic RatsMedical Science Monitor, 2015
- Cardiotrophin-1 Administration Protects from Ischemia-Reperfusion Renal Injury and InflammationTransplantation, 2013
- Dexmedetomidine protects against renal ischemia and reperfusion injury by inhibiting the JAK/STAT signaling activationJournal of Translational Medicine, 2013
- Notch2/Hes-1 Pathway Plays an Important Role in Renal Ischemia and Reperfusion Injury-Associated Inflammation and Apoptosis and the γ-Secretase Inhibitor DAPT has a Nephroprotective EffectRenal Failure, 2011
- Dexamethasone Ameliorates Renal Ischemia-Reperfusion InjuryJournal of the American Society of Nephrology, 2009